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Cervical sarcomas are extremely rare tumors associated with a poor prognosis. We report the case of a
63-year-old woman who was admitted to our institution due to abnormal vaginal bleeding and
abdominal pain. Physical examination revealed a large cervical mass that was biopsied. Pathological
features were compatible with a leiomyosarcoma of the uterine cervix. The patient underwent total
abdominal hysterectomy with bilateral salpingo-oophorectomy. All histological and Immunohisto-
chemical ﬁndings conﬁrmed the diagnosis of leiomyosarcoma of the cervix. Adjuvant chemotherapy was
started but unfortunately the disease progressed and 1 year after completion of the chemotherapy the
patient developed lung metastases and eventually died.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Primary sarcomas of the cervix are extremely rare neoplasms.
Due to the relative infrequency of this disease, there is a paucity of
reports in the literature and the available data regarding the natural
history of cervical sarcomas derive from case reports.1e7 To date,
Bansal et al1 have published the largest series, the authors identi-
ﬁed 323 patients with cervical sarcomas from a total of 33,074
women with invasive cervical neoplasms. Among cervical sar-
comas, leiomyosarcomas are exceedingly rare. In the literature,
they account for 21% of all cervical sarcomas, representing roughly
0.21% of all invasive cervical cancer cases.1
We present an unusual case of a cervical leiomyosarcoma with
lung metastasis in a postmenopausal woman.s of interest.
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A postmenopausal 63-year-old woman, Gravida 9/Para 8
(gravidity/parity) (G9P8), presented to the outpatient department
with complaints of worsening lower abdominal pain of ~1 month
duration. Pelvic examination revealed a large cervical mass and a
moderately enlarged uterus (~10 weeks gestation size). A biopsy of
the mass was obtained and the pathology report revealed ﬁndings
compatible with leiomyosarcoma. The endometrial stripe was very
difﬁcult to assess by transvaginal ultrasound due to the size of
tumor.
Magnetic resonance imaging (MRI) showed a large tumor
involving the uterine corpus and cervix, the right parametrium and
the paracervical area, measuring 11  11  14 cm (Fig 1A). A
positron emission tomography scan (PET) demonstrated only an
isolated increased uptake of the radioactive tracer conﬁned to the
lower pelvis. No distant metastases were evident. Laboratory
studies including CA-125 were within normal limits.
The patient underwent an exploratory laparotomy. No evidence
of ascites, retroperitoneal lymphadenectomy, or metastatic spreadally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig 1. (A) T2-weighted MRI showing a large cervical tumor measuring 11  11  14 cm with normal endometrial stripe and uterine corpus; (B) bisection of the uterus and
pathological mass. The uterine corpus and the adnexa were atrophic but with a normal appearance. The tumor over the uterine cervix consisted of heterogeneous content with an
area of hemorrhagic necrosis; (C) lung metastases shown in the x-ray.
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apparently arising from the cervix. The patient underwent total
abdominal hysterectomy, bilateral salpingo-oophorectomy, bilat-
eral pelvic lymphadenectomy, and omentectomy.
The gross surgical specimen conﬁrmed the presence of a pri-
mary cervical process. Bisection of both the uterus and the patho-
logical mass showed atrophic but normal appearance of the uterine
corpus and adnexa. The tumor over the uterine cervix, measured
11  11  14 cm, and consisted of a heterogeneous content with an
area of hemorrhagic necrosis (Fig 1B.). Histologically, tumor cell
necrosis was described, and the viable areas were composed of an
admixture of elongated spindle cells, with marked cytologic atypia
(Figs 2A and 2B). The mitotic index was superior to 10 mitosis per
10 high-power ﬁelds (HPF). Morphologically the tumor was Grade
3. The fallopian tubes, ovaries, pelvic lymph nodes, and the
omentum were all negative for malignancy. Immunohistochemical
studies showed that the tumor was diffusely positive for smoothFig 2. (A) In low-power ﬁeld, the tumor (left) is well circumscribed and some atypical cell
frequent mitosis and necrosis (H&E stain, 200); (C) the tumor is diffusely positive for smmuscle actin, focally positive for desmin, and negative for c-kit
(Figs 2C and 2D). The ﬁnal diagnosis was cervical leiomyosarcoma.
Following surgery, the patient was given six courses of cisplatin
(50 mg/m2) and ifosfamide (5 mg/m2) without radiation therapy.
Computed tomography (CT) performed 4 months after
completion of the chemotherapy regimen showed no evidence of
tumor recurrence. However, 1 year after completing chemotherapy,
the patient developed an intermittent productive cough. Chest x-
ray (CXR) revealed bilateral pulmonary metastases (Fig 1C). Un-
fortunately, 6 months later, the pulmonary disease progressed and
the patient eventually died due to respiratory failure.
Discussion
As stated previously, leiomyosarcomas of the uterine cervix are
exceptionally rare neoplasms. Before the report of Bansal et al1,
there were only 19 cases described in the literature.2,4 The Bansals can be seen [Hematoxylin and eosin (H&E) stain, 40]; (B) high-power ﬁeld reveals
ooth muscle actin; (D) the tumor is focally positive for desmin.
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henceforth, the incidence of this neoplasm is thought to be around
0.21% of all invasive cervical malignancies.
As a group, cervical leiomyosarcomas occur in a wide age range,
but they tend to arise in the perimenopausal period, with the
average age of diagnosis ranging between 19 and 79 years.1e3 The
most commonpresenting symptoms are abnormal vaginal bleeding
and a cervical mass. These tumors are typically large (up to 12 cm),
poorly circumscribed masses that either protrude from or expand
the cervicovaginal canal in a circumferential manner.
Several factors have been consistently found to demonstrate
value as prognostic indicators in patients diagnosed with uterine
leiomyosarcoma. Most important among these are tumor stage,
grade, andmitotic index. Other factors that are also described in the
literature include tumor size, age, and menopausal status. Bearing
this in mind, postmenopausal status, stage, older age (>51 years),
and large tumor size (>5 cm) are associated with a reduced likeli-
hood of survival.4
The histological criteria for the diagnosis of cervical leiomyo-
sarcoma comprise a spectrum of morphologic ﬁndings similar to
those seen in their corpus counterparts. Microscopically, the key
features may include, hyper- and hypocellular areas of elongated
spindled cells. Inﬁltrative margins may be present and vascular
invasion can also be found. The most important diagnostic criteria
are tumor cell necrosis, mitotic index  10/10 HPF, and diffuse to
moderate cytologic atypia.
Differential diagnosis includes secondary involvement of the
cervix by uterine corpus leiomyosarcoma and other rare neo-
plasms. Malignant melanoma, either primary or metastatic may be
excluded due to the expression of S100 and other melanocitic
markers. Pleomorphic rhabdomyosarcoma may also occur in older
women but they are usually seen in association with carcinosar-
coma (high-grade malignant glandular elements).8 Poorly differ-
entiated carcinoma may exhibit a spindled cell growth pattern but
immunostains for desmin may help in the diagnosis.9 A series of
cervicovaginal malignant peripheral nerve sheath tumors are rare
but occur in the same age group as leiomyosarcoma, however, some
degree of S100 staining is present and markers that suggest an
alternate line of differentiation can also be found.8 Extracardiac
rhabdomyoma may occur in the cervix or vagina but although
spindled cells may be present, typically cytologic atypia, tumor cell
necrosis, and mitotic ﬁgures are absent.9
As the number of reported cases in the literature is exceedingly
small, there is no established optimum means of management of
cervical leiomyosarcomas.4 Bearing in mind that the management
of cervical leiomyosarcomas may be extrapolated from their corpus
counterpart, abdominal hysterectomy with bilateral salpingo-oophorectomy (in postmenopausal women), or ovarian preserva-
tion in premenopausal women (the rate of ovarian metastasis is
low) should be the standard treatment for cervical leiomyosarco-
mas. Although routine pelvic lymphadenectomy should only be
carried out in women with clinically advanced leiomyosarcoma,
due to the size of the tumor we chose to perform pelvic
lymphadenectomy.
With regard to adjuvant therapy, there is no ﬁrm evidence that
adjuvant radiation therapy or chemotherapy is of beneﬁt to pa-
tients with uterine sarcomas.3 Data from the literature refer to both
nonimproved and improved survival (although statistically
nonsigniﬁcant) with adjuvant radiotherapy.4 However, the use of
postoperative radiation therapy may reduce the pelvic relapse rate
by ~50% and should be considered in patients at high risk for local
recurrence (tumors >5 cm, high mitotic index, and high grade
tumors).7
Most patients with advanced disease are considered candidates
for chemotherapy due to this tumor's tendency to metastasize
hematogenously. Several chemotherapy regimens have been
considered for patients with advanced leiomyosarcoma of the
uterus, including doxorubicin and ifosfamide, single-agent pacli-
taxel, and a combination of paclitaxel and carboplatin.3
In summary, because there is so little experience with cervical
leiomyosarcomas, its ultimate prognosis remains unclear. In our
patient the ﬁrst response either to the surgery and the chemo-
therapy was apparently favorable however, the patient developed
lung metastases. Thus, more cases and a longer follow-up are
needed to fully understand the clinical behavior of this tumor.References
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